Andrea Mega
Overview
Explore the profile of Andrea Mega including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
359
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giannini E, Pasta A, Torres M, Pieri G, Cabibbo G, Sangiovanni A, et al.
Liver Int
. 2025 Jan;
45(2):e16185.
PMID: 39776202
Background And Aims: Presence of active hepatitis C virus (HCV) infection may influence the outcome of patients treated for hepatocellular carcinoma (HCC), although this issue has never been adequately assessed...
2.
Calvaruso V, Celsa C, Cristoferi L, Scaravaglio M, Smith R, Kaur S, et al.
Clin Gastroenterol Hepatol
. 2024 Dec;
PMID: 39674236
Background & Aims: Noninvasive tests (NITs) for ruling-out clinical significant portal hypertension (CSPH) and high-risk varices (HRVs) in patients with primary biliary cholangitis (PBC) and compensated advanced chronic liver disease...
3.
Marzi L, Mega A, Turri C, Gitto S, Ferro F, Spizzo G
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519230
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the third leading cause of cancer-related death worldwide. Liver transplantation (LT) is the best therapy for most patients with...
4.
Bonatti M, Valletta R, Corato V, Gorgatti T, Posteraro A, Vingiani V, et al.
Insights Imaging
. 2024 Sep;
15(1):228.
PMID: 39298015
Focal liver lesions are frequently encountered during imaging studies, and hemangiomas represent the most common solid liver lesion. Liver hemangiomas usually show characteristic imaging features that enable characterization without the...
5.
Vitale A, Romano P, Cillo U, Lauterio A, Sangiovanni A, Cabibbo G, et al.
JAMA Surg
. 2024 May;
159(8):881-889.
PMID: 38771633
Importance: The 2022 Barcelona Clinic Liver Cancer algorithm currently discourages liver resection (LR) for patients with multinodular hepatocellular carcinoma (HCC) presenting with 2 or 3 nodules that are each 3...
6.
Giannini E, Pasta A, Pieri G, Torres M, Marseglia M, Pelizzaro F, et al.
Liver Int
. 2024 Mar;
44(7):1588-1599.
PMID: 38426262
Background & Aims: Chronic hepatitis D virus (HDV) often leads to end-stage liver disease and hepatocellular carcinoma (HCC). Comprehensive data pertaining to large populations with HDV and HCC are missing,...
7.
Stefanini B, Bucci L, Santi V, Reggidori N, Lani L, Granito A, et al.
Dig Liver Dis
. 2024 Feb;
56(9):1582-1591.
PMID: 38341377
Background And Aims: The efficacy of systemic therapy for unresectable advanced hepatocellular carcinoma (aHCC) has not been proven in patients with Child-Pugh (C-P) B cirrhosis. Nevertheless, in real-world these patients...
8.
Cabibbo G, Daniele B, Borzio M, Casadei-Gardini A, Cillo U, Colli A, et al.
Dig Liver Dis
. 2023 Dec;
56(3):394-405.
PMID: 38052656
Worldwide, hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death. The remarkable improvements in treating HCC achieved in the last years have increased the complexity of its...
9.
Cabibbo G, Daniele B, Borzio M, Casadei-Gardini A, Cillo U, Colli A, et al.
Dig Liver Dis
. 2023 Nov;
56(2):223-234.
PMID: 38030455
Worldwide, hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death. The remarkable improvements in treating HCC achieved in the last years have increased the complexity of HCC...
10.
Lynch K, Mega A, Daves M, Sadiq A, Fogarty H, Piccin A
Mediterr J Hematol Infect Dis
. 2023 Nov;
15(1):e2023060.
PMID: 38028400
In patients with SCD, chronic liver damage is a common manifestation. More than 50% of SCD patients have elevated liver enzymes. Common underlying aetiologies include sickle cell hepatic crisis, viral...